David F. Mobley, MD

Associate Professor Clinical Urology, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Recent advances in the treatment of erectile dysfunction
Mobley, DF, Khera, M & Baum, N 2017, Postgraduate Medical Journal, vol 93, no. 1105, pp. 679-685. DOI: 10.1136/postgradmedj-2016-134073

Improving operating efficiency with emphasis on prosthetic surgery
Baum, N, Mobley, DF & Perito, P 2015, Asian Journal of Andrology, vol 17, no. 4, pp. 686-688. DOI: 10.4103/1008-682X.142146

Early history of inflatable penile prosthesis surgery: A view from someone who was there
Mobley, DF 2015, Asian Journal of Andrology, vol 17, no. 2, pp. 225-229. DOI: 10.4103/1008-682X.140962

Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment
Mobley, D, Feibus, A & Baum, N 2015, Postgraduate Medicine, vol 127, no. 3, pp. 301-307. DOI: 10.1080/00325481.2015.1018799

Etiology, evaluation, and management of nocturia in elderly men and women.
Mobley, DF & Baum, N 2014, Postgraduate medicine, vol 126, no. 2, pp. 147-153. DOI: 10.3810/pgm.2014.03.2751

Urinary symptoms in patients with low back pain
Girard, L, Baum, N & Mobley, D 2013, Journal of Pain Management, vol 6, no. 2, pp. 95-103.

Medical management of benign prostatic hyperplasia in older adults
Mobley, DF & Baum, N 2004, Geriatrics and Aging, vol 7, no. 6, pp. 23-28.

Long-term safety and efficacy of oral phentolamine mesylate (Vasomax®) in men with mild to moderate erectile dysfunction
Padma-Nathan, H, Goldstein, I, Klimberg, I, Coogan, C, Auerbach, S, Lammers, P, Gleason, D, Young, J, Kaufman, J, Gittelman, M, Knoll, D, Wiatrak, M, Wells, G, Brito, G, Steidle, C, Susset, J, Talley, D, Feldman, R, Murdock, M, Childs, S, Zinner, N, Dula, E, Koukol, S, Knapp, P, Immergut, M, Snyder, J, Kornitzer, G, Belker, A, Barada, J, Byrne, J, Harris, R, McMahon, G, Mobley, D, Bloom, S, Kidd, D, Tomera, K & Lamm, S 2002, International Journal of Impotence Research, vol 14, no. 4, pp. 266-270. DOI: 10.1038/sj.ijir.3900885

The long-term effect of specific type II 5a-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trial
Matsumoto, AM, Tenover, L, McClung, M, Mobley, D, Geller, J, Sullivan, M, Grayhack, J, Wessells, H, Kadmon, D, Flanagan, M, Zhang, GK, Schmidt, J, Taylor, AM, Lee, M & Waldstreicher, J 2002, Journal of Urology, vol 167, no. 5, pp. 2105-2108.

Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
Kaplan, SA, Holtgrewe, HL, Bruskewitz, R, Saltzman, B, Mobley, D, Narayan, P, Lund, RH, Weiner, S, Wells, G, Cook, TJ, Meehan, A & Waldstreicher, J 2001, Urology, vol 57, no. 6, pp. 1073-1077. DOI: 10.1016/S0090-4295(01)00985-2

Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence
Versi, E, Appell, R, Mobley, D, Patton, W & Saltzstein, D 2000, Obstetrics and Gynecology, vol 95, no. 5, pp. 718-721. DOI: 10.1016/S0029-7844(99)00661-4

Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence
Anderson, RU, Mobley, D, Blank, B, Saltzstein, D, Susset, J & Brown, JS 1999, Journal of Urology, vol 161, no. 6, pp. 1809-1812. DOI: 10.1016/S0022-5347(05)68810-6

When patients request the impotence pill: Tips for office evaluation and treatment
Mobley, DF & Baum, N 1998, Postgraduate Medicine, vol 104, no. 2, pp. 55-66.

Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia
Mobley, DF, Dias, N & Levenstein, M 1998, Clinical Therapeutics, vol 20, no. 1, pp. 101-109. DOI: 10.1016/S0149-2918(98)80038-6

Effect of doxazosin on the symptoms of benign prostatic hyperplasia: Results from three double-blind placebo-controlled studies
Mobley, DF, Kaplan, S, Ice, K, Gaffney, M & Dias, N 1997, International Journal of Clinical Practice, vol 51, no. 5, pp. 282-288.

Doxazosin for benign prostatic hyperplasia: Long-term efficacy and safety in hypertensive and normotensive patients
Lepor, H, Kaplan, SA, Klimberg, I, Mobley, DF, Fawzy, A, Gaffney, M, Ice, K & Dias, N 1997, Journal of Urology, vol 157, no. 2, pp. 525-530. DOI: 10.1016/S0022-5347(01)65193-0

Interstitial cystitis: When urgency and frequency mean more than routine inflammation
Mobley, DF & Baum, N 1996, Postgraduate Medicine, vol 99, no. 5, pp. 201-214.

The Effect of Zanoterone, a Steroidal Androgen Receptor Antagonist, in Men with Benign Prostatic Hyperplasia
Berger, BM, Naadimuthu, A, Boddy, A, Fisher, HA, McConnell, JD, Milam, D, Mobley, D & Rajfer, JFTZSG 1995, The Journal of Urology, vol 154, no. 3, pp. 1060-1064.

Clinical experience with mentor alpha I inflatable penile prosthesis. Report on 333 cases
Randrup, E, Wilson, S, Mobley, D, Suarez, G, Mekras, G & Baum, N 1993, Urology, vol 42, no. 3, pp. 305-308.

Use of infrapubic incision for insertion of mentor Mark II inflatable penile prosthesis
Baum, N, Suarez, G & Mobley, D 1992, Urology, vol 39, no. 5, pp. 436-438.